Parkman Healthcare Partners’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-352,481
| Closed | -$4.93M | – | 94 |
|
|
2024
Q4 | $4.93M | Sell |
352,481
-92,915
| -21% | -$1.3M | 0.66% | 44 |
|
|
2024
Q3 | $10.1M | Sell |
445,396
-89,667
| -17% | -$2.03M | 1.29% | 26 |
|
|
2024
Q2 | $10.8M | Buy |
535,063
+10,810
| +2% | +$219K | 1.45% | 24 |
|
|
2024
Q1 | $13.1M | Buy |
524,253
+211,364
| +68% | +$5.26M | 1.6% | 19 |
|
|
2023
Q4 | $5.66M | Buy |
312,889
+190,168
| +155% | +$3.44M | 0.8% | 39 |
|
|
2023
Q3 | $2.47M | Sell |
122,721
-49,564
| -29% | -$996K | 0.45% | 62 |
|
|
2023
Q2 | $4.4M | Buy |
172,285
+24,486
| +17% | +$625K | 0.76% | 38 |
|
|
2023
Q1 | $3.14M | Buy |
147,799
+56,467
| +62% | +$1.2M | 0.68% | 47 |
|
|
2022
Q4 | $2.7M | Buy |
91,332
+9,968
| +12% | +$295K | 0.72% | 51 |
|
|
2022
Q3 | $1.89M | Buy |
81,364
+20,938
| +35% | +$487K | 0.54% | 59 |
|
|
2022
Q2 | $1.01M | Buy |
60,426
+3,131
| +5% | +$52.5K | 0.37% | 57 |
|
|
2022
Q1 | $2.51M | Sell |
57,295
-7,505
| -12% | -$329K | 0.74% | 44 |
|
|
2021
Q4 | $3.94M | Sell |
64,800
-4,749
| -7% | -$289K | 0.87% | 35 |
|
|
2021
Q3 | $2.89M | Sell |
69,549
-11,290
| -14% | -$470K | 0.73% | 41 |
|
|
2021
Q2 | $2.45M | Buy |
80,839
+5,385
| +7% | +$163K | 0.54% | 52 |
|
|
2021
Q1 | $2.25M | Buy |
+75,454
| New | +$2.25M | 0.52% | 51 |
|